{
  "trial_id": "NCT00735436",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "histologically confirmed diagnosis of WHO grade IV primary malignant glioma (glioblastoma multiforme or gliosarcoma)",
      "label": "met"
    },
    {
      "criterion": "age > or = 18 years",
      "label": "met"
    },
    {
      "criterion": "unilateral, single focus of measurable central nervous system (CNS) neoplasm on contrast-enhanced MRI",
      "label": "unknown"
    },
    {
      "criterion": "< or = 2 disease progressions",
      "label": "met"
    },
    {
      "criterion": "interval of at least 4 weeks from the end of prior radiotherapy or one week from the end of a cycle of chemotherapy",
      "label": "unknown"
    },
    {
      "criterion": "Karnofsky > or = 70%",
      "label": "met"
    },
    {
      "criterion": "Hemoglobin > or = 9.0 g/dl, absolute neutrophil count (ANC) > or = 1,500 cells/microliters, platelets > or = 125,000 cells/microliters",
      "label": "unknown"
    },
    {
      "criterion": "Serum creatinine < or = 1.5 mg/dl, serum glutamic-oxaloacetic transaminase (SGOT) and bilirubin < or = 1.5 times upper limit of normal",
      "label": "met"
    },
    {
      "criterion": "Patients on corticosteroids must have been on a stable dose for 1 week prior to entry, if clinically possible",
      "label": "unknown"
    },
    {
      "criterion": "Signed informed consent approved by the Institutional Review Board",
      "label": "met"
    },
    {
      "criterion": "No evidence of CNS hemorrhage on the baseline MRI or CT scans",
      "label": "met"
    },
    {
      "criterion": "If sexually active, patients will take contraceptive measures for the duration of treatment as stated in the informed consent",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy or breast feeding. Women of childbearing potential must have a negative serum pregnancy test within 72 hours prior to treatment administration",
      "label": "not_met"
    },
    {
      "criterion": "Multifocal disease",
      "label": "unknown"
    },
    {
      "criterion": "Prior treatment with Gliadel",
      "label": "met"
    },
    {
      "criterion": "Prior treatment with CPT-11 or Avastin",
      "label": "met"
    },
    {
      "criterion": "Prior stereotactic radiosurgery or brachytherapy",
      "label": "unknown"
    },
    {
      "criterion": "Co-medication that may interfere with study results; e.g. immuno-suppressive agents other than corticosteroids",
      "label": "met"
    },
    {
      "criterion": "Active infection requiring IV antibiotics",
      "label": "unknown"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and is currently on corticosteroids. However, they have not been on a stable dose for 1 week prior to entry.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00735436",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}